Managed Health Care Connect January 17, 2020
As we say goodbye to the 2010s, we look at the prevailing trends and project forward to what we think are the key topics to consider in the coming decade. Not an easy task. Looking back at commentary and predictions from 10 years ago, the main issues were the patent cliff and the move to specialty biologics. Some foresaw the rise of information technology impacting patient-consumer dynamics, but few envisaged the degree to which whole new areas of therapeutic development (eg, immuno and gene therapies) would gain traction. Read on… and pick up again in 2029 to see if we get it right.
A New Environment
The next decade will be all about reimagining patients in new ways and deeply...